SHARE
COPY LINK

HEALTH

Indian Covid variant detected in Switzerland

A first case of the Covid-19 variant contributing to the exploding outbreak in India has been detected in Switzerland, the public health authority said Saturday.

geneva-airport
A man wearing a protective face mask rides his bicycle past the entrance of Geneva Airport amid the COVID-19 outbreak, caused by the novel coronavirus, on May 28, 2020, in Geneva. (Photo by Fabrice COFFRINI / AFP)

“The first case of the Indian variant of Covid-19 has been discovered in Switzerland,” Switzerland’s Federal Office of Public Health said in a tweet.

The virus variant was found in “a passenger who arrived in Switzerland after transiting through a European airport.”

The tweet from the Federal Office of Public Health (BAG) in German, one of Switzerland’s official languages

The health authority corrected its initial announcement to make it clear that the passenger had transited in another European country before travelling to
Switzerland, rather than transiting in Switzerland itself.

The correction in French issued by the health authority on Twitter

“The person changed flights in a European country before flying on to Switzerland,” spokesman Daniel Dauwalder confirmed to AFP in an email, adding that the positive sample was collected in March in the northern canton of Solothurn.
  
The Federal Office of Public Health is meanwhile discussing whether to add India to its “red list” of high-risk countries, it said on Saturday.

Only a few days earlier, Swiss Interior and Health Minister Alain Berset said the government had decided not to put India on the red list as there were no direct flights between the country and Switzerland currently, according to Swiss website 20 Minuten.

People arriving from countries placed on Switzerland’s red list are required to quarantine for 10 days.

But Dauwalder pointed out that India already figured on a separate list held by the State Secretariat for Migration, which meant that for now, in most cases, only Swiss citizens and residents were permitted to enter Switzerland after a stay in India.

Swiss Interior and health Minister Alain Berset (R) speaks with Head of the infectious diseases department at the Federal Office of Public Health Virginie Masserey Spicher following a press conference on January 6, 2021, in Bern. (Photo by Fabrice COFFRINI / AFP)

READ ALSO: Germany restricts travel from high-risk India

Switzerland puts countries and regions on the red list once Covid-19 infection rates remain significantly higher than Switzerland’s for a period of 14 days.

Furthermore, the World Health Organisation has so far only listed the variant as a “variant of interest”, that is one that is “suspected” to be either more contagious than the original strain, cause more severe disease, or escape the protection offered by vaccines.

Manfred Weber, Leader of the European People’s Party in the European Parliament, has called for all flights from India to the EU to be completely stopped, warning that the situation was getting out of control, German daily Bild reported.

Countries have been on high alert for the new “double mutant” variant, known as B.1.617, with several having already suspended flights from India.

More contagious variant?

There is concern that vaccines protect less effectively against this variant because of the two mutations in key areas of the virus’ spike protein.

Professor Paul Hunter, a professor in medicine at the University of East Anglia, told The Guardian that the arrival of the India variant was potentially worrying.

“These two escape mutations working together could be a lot more problematic than the South African and Brazilian variants who have only got one escape mutation,” he said. “It might be even less controlled by vaccine than the Brazilian and South African variants.”

However, other experts were less concerned.

“It is not possible to discern a reliable trend from the few observations we have, but we should observe it closely,” Richard Neher, Head of the Evolution of Viruses and Bacteria Research Group at the University of Basel’s Centre of Molecular Life Sciences, according to Stern magazine.

Given the lack of knowledge about the many variants with noteworthy mutations, Neher said he did not believe that the Indian variant deserved any more concern than others.

Christian Drosten, a virologist at Berlin’s Charité teaching hospital, also did not see the new variant as a cause for concern, he said in an NDR podcast at the end of March.

READ ALSO: MAPS: Where in Switzerland are the highest and lowest Covid rates?

Since the start of the pandemic, in Switzerland and Liechtenstein, 646,509 people have tested positive for Covid-19 and 9,955 people have died from the virus, according to the Swiss Federal Office of Public Health.

As of April 21st, 9.8 percent of the population had been fully vaccinated against coronavirus with two doses of a vaccine.

The news of the variant’s arrival in Switzerland comes after Belgian authorities on Thursday said a group of 20 Indian nursing students who arrived from Paris had tested positive for the variant in the country.

India’s healthcare system is meanwhile buckling under a new wave of infections.

On Saturday, Covid-19 case numbers and deaths in the country set another grim new record.

The number of deaths across India climbed by 2,624 in the 24 hours to Saturday, up from Friday’s 2,263, as the country struggles to cope amid full intensive care units and a shortage of oxygen supplies.

A total of almost 190,000 people have died of coronavirus in India, according to official figures.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.
For members

HEALTH

Reader question: Do I have to pay for prescription drugs in Switzerland?

Generally speaking, medications prescribed by a doctor are covered by healthcare insurance. But this doesn’t mean you won’t have to pay any costs at all.

Reader question: Do I have to pay for prescription drugs in Switzerland?

As is the case everywhere else, there are two types of medicines in Switzerland: those you buy without a prescription (over-the-counter — OTC) and those who are by doctor’s orders only.

As a general rule, compulsory health insurance (KVG in German and LaMal in French and Italian) reimburses medicines prescribed by a doctor, as long as they are included on the list of drugs officially approved by Switzerland’s regulatory body, Swissmedic — in total, about 2,500 medications.

The list is quite extensive, comprising not only brand-name and generic meds but also many biosimilars — medicines that are almost an identical copy of an original product manufactured by a different company.

Also covered are some alternative-medicine drugs, including homeopathy and physiotherapy. 

What happens when a doctor prescribes a drug that is not authorised in Switzerland?

In principle, the compulsory health insurance will not cover the costs and you will have to pay for it yourself.

However, there are exceptions to this rule.

For instance, even if a particular medication is not approved in Switzerland, but is imported from a country where it is authorised by a body that is considered equivalent to Swissmedic (for example, the European Medicines Agency), then KVG / LaMal will pay for it.

Also, if the cost of a drug is not covered by the compulsory health insurance, and you have taken out a complementary policy, it is possible the latter will pay for it.

These insurance providers have their own lists of medicines which they cover, though certain conditions and limitations may apply.

In general, neither basic nor supplementary insurance will pay for so-called  Pharmaceuticals for Special Application (LPPA). This list mainly includes “comfort” products, for example appetite suppressants or products that reduce hair loss.

READ ALSO: Should you buy supplemental health insurance in Switzerland?

How much of the cost does insurance pay?

As is the case for medical treatments in general, KVG / LaMal will pay 90 percent of the cost of medication for which no generics exist.

If, however, an equivalent generic drug is available, but you still choose the brand medicine, then your insurance carrier will cover 80 percent of the price. This means that you will have to pay either 10 or 20 percent of the cost yourself.

This will happen until you use up our entire deductible (franchise), in addition to your 10-percent share of the costs that exceed the deductible — a maximum of 700 francs per year for adults and 350 francs for children.

If you have a low deductible (300 francs), this means that once you use up 1,000 francs toward your medical costs (doctor’s visits, treatments, and medicines combined), you will then not have to pay anything toward your prescription drugs.

By the same token, if you have chosen the highest franchise — 2,500 francs — and add to it the 700-franc co-pay, you may never get to the point where all your medications will be completely covered by the insurance.

READ ALSO: Which Swiss health insurance deductible makes most sense?

SHOW COMMENTS